David Lemus
Director at Silence Therapeutics plc (SLN) since January 2025
David Lemus has filed 8 insider reports with the SEC since August 2021, as director at Silence Therapeutics plc (SLN), director at Scilex Holding Co (SCLX) and director at Sorrento Therapeutics, Inc. (SRNE). David Lemus made no open-market purchases or sales in the last 12 months. The latest filing, on January 6, 2026, reports grant or award at Silence Therapeutics plc (SLN).
- Filings
- 8
- Companies
- 3
- Bought on market
- $1,800
- Sold on market
- None
Companies where David Lemus is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince January 2025 | 7,527 | $19.81 | Jan 6, 2026 | ||||
| Directorsince November 2022 | 2,000 | $1,800 | $0.90 | $0.5658-37% | Oct 18, 2024 | ||
| Director | Aug 31, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jan 2, 2026SLNSEC Form 4 filed by Director Lemus DavidForm 4Grant or award
- Jan 2, 2025SLNSEC Form 4 filed by Director Lemus DavidForm 4Grant or award
- Jan 2, 2025SLNNew insider Lemus David claimed ownership of 7,527 units of Ordinary SharesForm 3New insider
- Oct 17, 2024+$1,800SCLXDirector Lemus David bought $1,800 worth of shares (2,000 units at $0.90)Form 4Open-market purchase
- Mar 15, 2024SCLXSEC Form 4 filed by Director Lemus DavidForm 4Grant or award
- Jan 17, 2023SCLXSEC Form 4 filed by Lemus DavidForm 4Grant or award
- Nov 10, 2022SCLXDavid Lemus became an insiderForm 3New insider
- Aug 30, 2021SRNESEC Form 4 filed by Lemus DavidForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with David Lemus.
- Henry Ji2 shared: SCLX, SRNE
- Yue Alexander Wu2 shared: SCLX, SRNE
- Dorman Followwill2 shared: SCLX, SRNE
- Jaisim Shah2 shared: SCLX, SRNE
- Elizabeth Czerepak2 shared: SCLX, SRNE
Compare David Lemus with
- David Lemus vs Henry Ji2 shared
- David Lemus vs Yue Alexander Wu2 shared
- David Lemus vs Dorman Followwill2 shared
- David Lemus vs Jaisim Shah2 shared
- David Lemus vs Elizabeth Czerepak2 shared
- David Lemus vs Richard Ian Griffiths1 shared
Other insiders at the same companies
- Richard Ian GriffithsSLN
- SCLX Stock Acquisition JV LLCSCLX
- Holding Co ScilexSCLX
- Stephen Hoi MaSCLX
- James Ede-GolightlySLN
- Steven J. RomanoSLN
- Timothy McinerneySLN
- Rhonda Lynette HellumsSLN
- Iain RossSLN
- Jay ChunSCLX
- Michael H. DavidsonSLN
- Craig A ToomanSLN
Questions about David Lemus
- What is David Lemus's role at Silence Therapeutics plc?
- David Lemus reports to the SEC as director at Silence Therapeutics plc (SLN), according to the latest filing on January 6, 2026. David Lemus has also filed as director at Scilex Holding Co (SCLX) and director at Sorrento Therapeutics, Inc. (SRNE).
- How many shares does David Lemus own?
- After the latest filing that states it, David Lemus directly owned 7,527 shares of Silence Therapeutics plc (SLN) and 2,000 shares of Scilex Holding Co (SCLX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has David Lemus bought or sold stock recently?
- The most recent open-market purchase was on October 17, 2024: bought 2,000 shares of Scilex Holding Co (SCLX) for $1,800 at an average of $0.90.
- How do I get alerts when David Lemus files?
- Follow David Lemus on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by David Lemus (SEC CIK 0001717972). Totals count each trade once, skipping amendments whose original is on file, from Aug 31, 2021 on. View on SEC EDGAR · Get this as JSON